1. Home
  2. SCOR vs CALC Comparison

SCOR vs CALC Comparison

Compare SCOR & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo comScore Inc.

SCOR

comScore Inc.

HOLD

Current Price

$6.27

Market Cap

112.4M

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$0.62

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCOR
CALC
Founded
1999
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.4M
9.7M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
SCOR
CALC
Price
$6.27
$0.62
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
10.8K
126.0K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
127.37
N/A
EPS
4.25
0.30
Revenue
$403,549,000.00
N/A
Revenue This Year
$2.75
N/A
Revenue Next Year
$7.30
N/A
P/E Ratio
$1.53
$2.18
Revenue Growth
1.02
N/A
52 Week Low
$4.39
$0.46
52 Week High
$10.18
$7.20

Technical Indicators

Market Signals
Indicator
SCOR
CALC
Relative Strength Index (RSI) 35.56 47.64
Support Level $6.22 $0.50
Resistance Level $7.07 $0.78
Average True Range (ATR) 0.39 0.05
MACD -0.11 0.01
Stochastic Oscillator 8.92 46.51

Price Performance

Historical Comparison
SCOR
CALC

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

Share on Social Networks: